ArticleBMC global and public health2026
Geostatistical analysis of baseline prevalence and treatment history drastically reduces the cost of soil-transmitted helminth impact assessment surveys.
Article in BMC global and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImpact assessment surveys (IAS) are central to monitoring and evaluating the effectiveness of mass drug administration (MDA) programs targeting soil-transmitted helminths (STH). Current survey designs often follow guidelines that lack flexibility and spatial representativeness. There is a need for more efficient and context-adaptable methodologies that can guide programmatic decision-making using available data.
methodsWe developed a three-step geostatistical framework for optimal IAS design that integrates baseline prevalence data, environmental covariates, and treatment history. A geostatistical model is used to estimate baseline prevalence. A Markov model, coupled with a local spatial thinning algorithm, is then applied to forecast post-MDA prevalence surfaces. These projections guide the simulation and evaluation of candidate survey designs across different sampling intensities and spatial configurations. Design performance was assessed based on classification accuracy and survey cost.
resultsThe methodology was applied to datasets from Kenya, Sierra Leone, and Zimbabwe. Compared to conventional survey designs, our model-based approach achieved similar classification accuracy with 60-90% lower survey costs. These gains were consistent across settings with different endemicity levels and deworming histories. The results also highlight the importance of leveraging spatial correlation and historical program data to inform efficient design.
conclusionsOur approach offers a flexible and cost-effective solution for designing IAS under real-world constraints. By incorporating spatial modeling and intervention history, it enables evidence-based decision-making and resource allocation. This framework is disease-agnostic and can be adapted to other neglected tropical diseases to support progress toward control and elimination goals.
Indexed as
Identifiers
42919436What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.